COVID-19 vaccine trial to understand how it works in a wider age group. White House blocks new coronavirus vaccine guidelines that would delay approval The U.S.
Food and Drug Administration granted permission to the drugmaker and German partner BioNTech SE to enroll the younger participants this month, according to an update on Monday on the U.S.
company’s website.The drugmaker is racing with rivals such as Johnson & Johnson, Moderna Inc and AstraZeneca Plc to develop a safe and effective vaccine for the coronavirus.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]The companies have pledged to ensure diversity in terms of race, ethnicity, gender, age and other factors in their vaccine studies.Pfizer last month.